Convergence Investment Partners, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 93 filers reported holding ACCELERON PHARMA INC in Q2 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.9%.

Quarter-by-quarter ownership
Convergence Investment Partners, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2019$149,000
-81.6%
3,764
-84.0%
0.04%
-65.9%
Q1 2014$809,00023,4600.12%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2014
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 2$3580.00%
View complete list of ACCELERON PHARMA INC shareholders